Ophthotech reported $333.15M in Equity Capital and Reserves for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Alimera Sciences ALIM:US $ -8.6M 6M
Applied Genetic Technologies AGTC:US $ 47.03M 4.46M
Bioline Rx BLRX:US $ 63.41M 4.67M
Cytrx CYTR:US 3.28M 1.5M
Insmed INSM:US $ 119.88M 290.59M
Nektar Therapeutics NKTR:US $ 607.89M 71.62M
Novartis NOVN:VX SF 61540M 6115M
Ophthotech OPHT:US $ 333.15M 27.37M
Regeneron Pharmaceuticals REGN:US $ 19914.7M 1145.9M